Össur advances in all areas after Covid-19-affected year

The Asian market has especially influenced growth at Icelandic orthopedics equipment manufacturer Össur in Q1, while many other markets are still suffering from extensive lockdowns.

Össur CEO & President Jon Sigurdsson | Photo: Össur/PR

The prosthetic business grew organically by 3 percent in the first quarter of the year at Icelandic orthopedics manufacturer Össur. This is a solid improvement compared with the same quarter last year, during which the same business leg shrunk by 4 percent.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs